These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34951389)

  • 1. Influence of Drugs on Mild Cognitive Impairment in Parkinson's Disease: Evidence from the PACOS Study.
    Cicero CE; Monastero R; Terravecchia C; Donzuso G; Luca A; Baschi R; Caccamo M; Mostile G; Giuliano L; Zappia M; Nicoletti A
    Curr Neuropharmacol; 2022; 20(5):998-1003. PubMed ID: 34951389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study.
    Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA
    Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
    Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
    Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
    Yarnall AJ; Lawson RA; Duncan GW; Breen DP; Khoo TK; Brooks D; Barker RA; Taylor JP; Burn DJ
    J Parkinsons Dis; 2015; 5(4):743-7. PubMed ID: 26444094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild Behavioral Impairment in Parkinson's Disease: Data from the Parkinson's Disease Cognitive Impairment Study (PACOS).
    Baschi R; Restivo V; Nicoletti A; Cicero CE; Luca A; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2019; 68(4):1603-1610. PubMed ID: 30909234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular autonomic function and MCI in Parkinson's disease.
    Cicero CE; Raciti L; Monastero R; Mostile G; Donzuso G; Sciacca G; Luca A; Terravecchia C; Giuliano L; Baschi R; Davì M; Zappia M; Nicoletti A
    Parkinsonism Relat Disord; 2019 Dec; 69():55-58. PubMed ID: 31677456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.
    Lawson RA; Yarnall AJ; Duncan GW; Khoo TK; Breen DP; Barker RA; Collerton D; Taylor JP; Burn DJ
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1071-5. PubMed ID: 25074728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson's disease with mild cognitive impairment.
    Cicero CE; Donzuso G; Luca A; Davì M; Baschi R; Mostile G; Giuliano L; Palmucci S; Salerno A; Monastero R; Nicoletti A; Zappia M
    Eur J Neurol; 2022 Nov; 29(11):3197-3204. PubMed ID: 35790057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
    Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
    J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.